Remember me:
Register here
Skip Navigation LinksHI article
Christopher Baker named chairman of GSTS Pathology

The Serco-backed joint venture GSTS Pathology has named Christopher Baker as its independent chairman in a newly created role.

Baker joins the group with experience in both the public and private sectors, having been chairman of Aintree University Hospital NHS Foundation Trust, and a non-executive director of Park Group and Ai Claims Solutions.

GSTS Pathology’s chief executive, Richard Jones, commented: “This is a pivotal appointment to the board and I believe that Christopher brings a superb mix of skills and experience to work with me and the board to steer GSTS through the next phase of its development.”

Baker added: “GSTS has a hugely exciting opportunity to demonstrate how a public-private sector partnership can transform the delivery of a key healthcare service and support the NHS’s drive for efficiency. I am greatly looking forward to joining GSTS Pathology to support the delivery of this vision.”

GSTS Pathology is the largest independent pathology provider in the UK with around 1,000 employees.

The original partnership between Guy’s and St Thomas’ NHS Foundation Trust and Serco went live in 2009, with King’s College Hospital NHS Foundation Trust joining the joint venture in 2010.


Posted on: 03/05/2012


Latest news stories

Hunt plans £260m technology fund for hospitals
17/05/2013
Health secretary Jeremy Hunt has announced a £260 million fund for hospitals to “go digital” by 2018.
Exclusive: Nuffield and HCA vie for NHS-backed Manchester facility
17/05/2013
Nuffield Health and HCA International are competing to open a new private healthcare facility as part of Manchester’s MediPark development, HealthInvestor can reveal.
Gross revenues fall at PuriCore
17/05/2013
PuriCore, which creates water-based decontamination solutions, has experienced a 23.7% drop in revenue to $10.9 million (£7.2 million) from $14.3 million dollars for the same period last year.
CBI to create transparency guidelines for private providers of NHS services
16/05/2013
The Confederation of British Industry is developing transparency guidelines for private companies that run public services, according to the Health Service Journal.
Nuffield Health sees ebitda increase by 14%
15/05/2013
Ebitda at not-for-profit private healthcare provider Nuffield Health has risen by 14% to £82 million since 2011 and 21% since 2010.


Outsourcing:
The missing link
Can outsourcing firms drive integration – and their own profits – by partnering with the NHS, asks Ploy Radford
Read more...

View the finalists
Property:
Brit prop
The health property sector has had to look abroad for its cash of late. Can it attract UK capital once again? Adrian Murdoch reports
Read more...
Brit prop Requires login
The health property sector has had to look abroad for its cash of late. Can it attract UK capital once again? Adrian Murdoch reports
Baby boom
Demand for IVF treatment is on the rise, and is providing fertile ground for companies like Care Fertility Group. Catherine Llewellyn reports
Share and share alike Requires login
A study of global healthcare explores how health systems around the world can cope with rapidly growing and ageing populations. Catherine Llewellyn investigates
Number crunching Requires login
Bupa has big plans to tackle some of the problems in the UK’s private healthcare market, its new managing director of health funding tells Ploy Radford
The missing link Requires login
Can outsourcing firms drive integration – and their own profits – by partnering with the NHS, asks Ploy Radford

Click here to search all feature articles





HealthInvestor Subscriber Comments

To post a comment please sign in or sign up to HealthInvestor
return